OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0938-AU96         View EO 12866 Meetings	Received Date: 09/01/2022
Title: Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Program for Contract Year 2024 (CMS-4201)
Agency/Subagency: HHS / CMS	Stage: Proposed Rule
Concluded Action: Consistent with Change	Concluded Date: 12/07/2022
Legal Deadline: Statutory	Economically Significant: Yes
Publication Date: 12/27/2022	Unfunded Mandates: No
Major: Yes	Related To Homeland Security: No
Regulatory Flexibility Analysis Required: No	Small Entities Affected:
Federalism Implications: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: No